- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.05. | RxSight Non-GAAP EPS of -$0.03 beats by $0.05, revenue of $37.9M in-line | 1 | Seeking Alpha | ||
| 07.05. | RxSight, Inc. - 8-K, Current Report | - | SEC Filings | ||
| RXSIGHT Aktie jetzt für 0€ handeln | |||||
| 15.04. | Piper Sandler sets RxSight stock target at $18, stays neutral | 1 | Investing.com | ||
| 09.04. | RxSight downgraded at UBS after Q1 miss and guidance cut | 4 | Seeking Alpha | ||
| 09.04. | UBS cuts RxSight stock rating to neutral, slashes price target to $16 | 2 | Investing.com | ||
| 04.04. | SA Rating Changes: CHTR, RIVN, EE, WASH, DV, LZ, RXST | 7 | Seeking Alpha | ||
| 04.04. | JP Morgan downgrades RxSight on market, competitive pressures | 4 | Investing.com | ||
| 04.04. | Deep Dive Into RxSight Stock: Analyst Perspectives (12 Ratings) | 3 | Benzinga.com | ||
| 03.04. | JPMorgan cuts RxSight stock rating, slashes price target to $17 | 3 | Investing.com | ||
| 03.04. | Rxsight adjusts 2025 revenue guidance to $160M-$175M amid premium IOL market challenges | 1 | Seeking Alpha | ||
| 03.04. | RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations | 1 | Benzinga.com | ||
| 03.04. | RxSight-Aktie stürzt nach gesenkter Prognose für 2025 ab | 3 | Investing.com Deutsch | ||
| 03.04. | RxSight stock tumbles on lowered 2025 guidance | 1 | Investing.com | ||
| 03.04. | BTIG cuts RxSight stock price target to $28 from $44 | 2 | Investing.com | ||
| 03.04. | Stifel maintains RxSight stock hold, price target at $28 | 2 | Investing.com | ||
| 03.04. | RxSight plunges after guidance cut | 2 | Seeking Alpha | ||
| 03.04. | RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges | 2 | Benzinga.com | ||
| 03.04. | Needham maintains Buy on RxSight stock, price target at $43 | 2 | Investing.com | ||
| 03.04. | RxSight Expects 28% Growth In Q1 Revenue; Cuts FY25 Revenue Outlook | 1 | RTTNews | ||
| 03.04. | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | 203 | GlobeNewswire (Europe) | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |
Seite:
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 64,50 | +1,98 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Quartalsergebnis
Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose
13.05.2025 / 07:45... ► Artikel lesen | |
| UNITEDHEALTH | 252,25 | +2,90 % | UnitedHealth holt früheren Chef zurück und streicht Jahresziele - Aktie sackt ab | MINNEAPOLIS (dpa-AFX) - Der größte US-Krankenversicherer UnitedHealth streicht sein Gewinnziel für 2025 und tauscht seinen Chef aus. Der frühere Konzernchef Stephen Hemsley übernehme mit sofortiger... ► Artikel lesen | |
| HIMS & HERS HEALTH | 53,30 | +1,72 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| RESMED | 222,40 | +0,04 % | Resmed, Inc.: Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 | SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the... ► Artikel lesen | |
| SENSEONICS | 0,496 | +1,49 % | Senseonics announces pricing of $50 million public offering | ||
| BONESUPPORT | 25,960 | -0,08 % | Bonesupport Holding AB: Upcoming CEO change. Emil Billbäck will transfer to a role as Senior Advisor. Torbjörn Sköld will start as CEO effective September 1st, 2025 | BONESUPPORT, a leading company in orthobiologics for the management of bone injuries, today announces the coming transition of leadership at Bonesupport.
Lennart Johansson states: Emil Billbäck will... ► Artikel lesen | |
| LANTHEUS | 71,56 | +0,28 % | Lantheus Holdings, Inc.: Lantheus Announces Sale of SPECT Business to SHINE Technologies | Enables Lantheus to focus on innovative radiopharmaceuticals, while maximizing the value of its SPECT business SHINE will acquire products TechneLite®, NEUROLITE®, Xenon Xe-133 Gas, and Cardiolite®... ► Artikel lesen | |
| TRANSMEDICS GROUP | 109,40 | +0,51 % | Why TransMedics Group (TMDX) Is Among the Best Performing Healthcare Stocks to Buy Now | ||
| INSPIRE MEDICAL SYSTEMS | 131,45 | -2,16 % | Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook | Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire... ► Artikel lesen | |
| ALPHATEC | 11,165 | -0,18 % | Alphatec Holdings, Inc. Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook | CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary... ► Artikel lesen | |
| CHEMOMETEC | 67,60 | +0,75 % | Chemometec A/S: Continued growth in revenue and operating profit | Trading statement for Q3 2024/25 (1 January - 31 March 2025) Continued growth in revenue and operating profit Revenue was up by 26% in the third quarter of 2024/25 to DKK 124.2 million from DKK 98.9... ► Artikel lesen | |
| OPTIMIZERX | 10,630 | 0,00 % | OptimizeRX stock target raised to $14 by JMP Securities | ||
| KINDLY MD | 13,830 | 0,00 % | David Bailey and Bitcoin-Native Holding Company Nakamoto Announce Merger with KindlyMD to Establish Bitcoin Treasury | Raises $510 Million PIPE and $200 Million in Convertible Notes Marking Largest Capital Raise to Launch a Bitcoin Treasury and the Largest PIPE for Any Public Crypto-Related Transaction
David Bailey... ► Artikel lesen | |
| FRESENIUS | 42,920 | +2,75 % | Fresenius SE & Co. KGaA-Aktie: Kurs mit wenig Bewegung (42,94 €) | Der Kurs der der Aktie von Fresenius SE & Co. KGaA kommt kaum von der Stelle. Der jüngste Kurs betrug 42,94 Euro. Ein minimales Kursplus von 0,09 Prozent zeigt die Kurstafel für das Wertpapier von Fresenius+Co... ► Artikel lesen | |
| GENEDX | 63,73 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies |
Das Unternehmen RXSIGHT INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 13,295 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RXSIGHT INC finden Sie auf Wallstreet Online.